Terns Pharmaceuticals, Inc.

TERNDelisted May 5, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001831363

SEC filings (opens in a new tab)

Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.

Q4 2023 vs. Q3 2023

How the institutions holding Terns Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of TERN: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Of which not filed for Q4 2023	Q4 2023	Change
Holders	93	1	103	+11
Shares	61.7M	714.3K	63.6M	+2.59M (+4.2%)
Value	$310.4M	$3.59M	$412.7M	+$105.9M (+34.5%)

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Terns Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to TERN in Q4 2023
Institution	Shares	Value	% of portfolio
Janus Henderson Group PLC	1,424,763	$9.25M	0.01%
Decheng Capital LLC	714,285	$4.64M	1.30%
Russell Investments Group, Ltd.	277,741	$1.80M	0.00%
MYDA Advisors LLC	142,383	$924.1K	0.41%
Jane Street Group, LLC	64,453	$418.3K	0.00%
ExodusPoint Capital Management, LP	47,540	$309.0K	0.00%
EntryPoint Capital, LLC	28,285	$183.6K	0.18%
UBS Asset Management Americas Inc	17,870	$116.0K	0.00%
Deerfield Management Company, L.P. (Series C)	17,290	$112.2K	0.00%
Dynamic Technology Lab Private Ltd	16,322	$106.0K	0.01%
Martingale Asset Management L P	15,469	$100.4K	0.00%
Balyasny Asset Management LLC	13,854	$89.9K	0.00%
ADAR1 Capital Management, LLC	13,007	$84.4K	0.04%
ProShare Advisors LLC	11,042	$71.7K	0.00%
Brevan Howard Capital Management LP	10,842	$70.4K	0.01%
Sawtooth Solutions, LLC	10,452	$67.8K	0.00%
Bleakley Financial Group, LLC	10,452	$67.8K	0.00%
AJOVista, LLC	8,943	$58.0K	0.07%
Quadrant Capital Group LLC	339	$2.20K	0.00%
Fortitude Family Office, LLC	300	$1.95K	0.00%
Simplex Trading, LLC	170	$1.00K	0.00%
GAMMA Investing LLC	144	$746	0.00%
Parallel Advisors, LLC	114	$740	0.00%
ICA Group Wealth Management, LLC	80	$519	0.00%
Farther Finance Advisors, LLC	20	$130	0.00%
The PNC Financial Services Group, Inc.	8	$52	0.00%

Sold out (15)

Institutions that held Terns Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of TERN in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Point72 Asset Management, L.P.	571,265	$2.87M
Renaissance Technologies LLC	290,100	$1.46M
Cubist Systematic Strategies, LLC	135,015	$679.1K
Polar Asset Management Partners Inc.	100,000	$503.0K
Graham Capital Management, L.P.	82,978	$417.4K
Connor, Clark & Lunn Investment Management Ltd.	67,957	$341.8K
Alps Advisors Inc	45,028	$226.5K
Parkman Healthcare Partners LLC	41,728	$209.9K
XTX Topco Ltd	33,055	$166.3K
Trexquant Investment LP	31,695	$159.4K
Bridgeway Capital Management, LLC	27,500	$138.3K
PEAK6 Investments LLC	19,097	$96.1K
AQR Capital Management LLC	17,014	$85.6K
Point72 Middle East FZE	13,849	$69.7K
Kovack Advisors, Inc.	10,200	$51.3K

Not filed for Q4 2023 yet (1)

Institutions that held Terns Pharmaceuticals, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TERN in Q3 2023 that haven't filed for Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Decheng Capital Management III (Cayman), LLC	714,285	$3.59M